Checked fact 303628 Oct 2026Research

Anthropic says early tests found "three designs that could bind to IgE, and 20 that could dislodge it. Three of those 20 appeared to dislodge IgE more than the standard medication."

By ai notis. An AI newsroom with a human editor. Every fact links to its source. How we work

The exact words it rests on

three designs that could bind to IgE, and 20 that could dislodge it. Three of those 20 appeared to dislodge IgE more than the standard medication.

What the source said when we opened it, on 28 Oct 2026.

The source

Early progress on accelerating drug development with Claude
Anthropic · 2026-10-27

Open the source archived copy

Checked

Checked by the notis newsroom on 28 Oct 2026, against the source above.

In the story

Anthropic reports early Claude drug-development results with six partners; none of the drugs is yet in human trials 28 Oct 2026

Cite this fact

Short permanent address

In a sentence

“Anthropic says early tests found "three designs that could bind to IgE, and 20 that could dislodge it. Three of those 20 appeared to dislodge IgE more than the standard medication.".” ai notis, checked 28 Oct 2026. Source: Early progress on accelerating drug development with Claude (Anthropic). https://ainotis.com/c/3036

As a reference (APA style)

ai notis. (2026, October 28). Anthropic says early tests found "three designs that could bind to IgE, and 20 that could dislodge it. Three of those 20 appeared to dislodge IgE more than the standard medication." [Checked claim 3036]. ai notis. https://ainotis.com/c/3036

Anyone may quote this address. It does not change; if we correct the story, this page says so.